Related Experiment Video
Updated: Jul 17, 2026
08:08
Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
Published on: February 27, 2015
Comparative proteomics of small cell lung carcinoma
Tamar Ziv1, Eilon Barnea, Hava Segal
1Department of Biology, The Smoler Proteomics Center, Technion, Haifa, Israel.
Cancer Biomarkers : Section a of Disease Markers
|February 1, 2007
Summary
Researchers identified 202 proteins unique to small cell lung carcinoma (SCLC) cells. These proteins, including those involved in neuroendocrine development, show potential as novel biomarkers and immunotherapy targets for this aggressive cancer.
Area of Science:
- Proteomics
- Oncology
- Biochemistry
Background:
- Small cell lung carcinoma (SCLC) is an aggressive cancer known for metastasis and chemotherapy resistance.
- Identifying SCLC-specific proteins is crucial for developing diagnostics, improving immunotherapies, and understanding disease mechanisms.
Purpose of the Study:
- To conduct a comparative proteomics analysis to find proteins preferentially expressed in SCLC cells.
- To identify potential novel biomarkers and therapeutic targets for SCLC.
Main Methods:
- Comparative proteomics analysis of ten SCLC cell lines and three control cell lines.
- Utilized two-dimensional gel electrophoresis and two-dimensional liquid chromatography for protein comparison.
Main Results:
- Identified a total of 1093 proteins across all cell lines.
- Discovered 202 proteins exclusively detected in SCLC cells.
- These proteins encompass diverse cellular functions, including proliferation, tumor antigens, and nerve/brain embryonic development pathways.
Conclusions:
- Proteins uniquely expressed in SCLC, particularly those related to neuroendocrine functions, represent promising candidates for SCLC tumor markers.
- These identified proteins may also serve as valuable antigens for developing novel immunotherapies against SCLC.
